Nuvama Fund cuts Sudeep Pharma stake to 6.0% via open market sales

FII holding declinedOwnership Changes View source PDF Explain this filing

SUDEEPPHRM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.8%Reaction day

₹862.05

prior close

₹864.10

announcement price

In-mkt

timing

Nifty Microcap 250market+0.5%+1.3% vs market

Specialty Chemicals peers, median of 93sector+0.5%+1.3% vs sector

On the reaction day the stock moved 1.3 pts more than Nifty Microcap 250 and 1.3 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.3

10m

+0.7

15m

+1.1

30m

+1.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.8+0.5+1.3+0.5+1.3

Next day

-0.3-0.1-0.2-0.9+0.6

+2.1+1.0+1.1-0.2+2.3

+0.4+2.3-1.9+0.8-0.4

+1.3+2.8-1.5+1.2+0.1

+11.2+4.1+7.2+1.6+9.6

+11.4+4.5+6.9+2.2+9.2

15d

+34.2+4.8+29.4+1.0+33.2

+40.3+6.4+33.9+3.2+37.2

+38.7+5.5+33.2+1.3+37.4

+31.6-1.7+33.3-4.4+35.9

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 93Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Nuvama Crossover Opportunities Fund sold 26,68,118 shares (2.4%) of Sudeep Pharma in the open market between 15 June and 24 July 2026, reducing its stake from 8.4% to 6.0%. The fund originally held 94,51,295 shares acquired via pre-IPO preferential allotment and IPO buying. Nuvama is not classified as a promoter. The 2% cumulative change triggered disclosure under SEBI takeover rules.

Likely market impact

Institutional selling may pressure stock near-term. Holding drop from 8.4% to 6.0% signals reduced FII interest.